← Browse by Condition
Medical Condition

monoclonal gammopathy of uncertain significance

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05939037 Phase 2
Recruiting

Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy

Enrollment
35 pts
Location
Netherlands
Sponsor
UMC Utrecht
View Trial →